Blog

How to Design Empathetic eConsent, Cut Costs & Support Caregivers

Practical strategies to design empathetic eConsent for elderly participants, cut financial burdens in oncology enrollment, enable compassionate remote monitoring, and strengthen caregiver support for head and neck trials.

Trends Shaping Equitable, Culturally Tailored Trial Recruitment

Stories of Maria and Harold show how language, culture, and age-focused changes—community outreach, translated consent, flexible visits—are reshaping recruitment so trials better serve everyone, with hope and practical steps forward.

Case Study: Edge Wearables, AI Biomarkers & Decentralized Trials

Five case-study insights on edge wearables, AI biomarkers and decentralized trials — practical trade-offs, global regulatory considerations and what teams should bring to a first visit.

How do Lean Six Sigma & EHR pipelines cut elderly dropout in oncology?

Operational convergence — Lean Six Sigma, EHR recruitment, risk-based monitoring and decentralized consent — is cutting elderly dropout in oncology. Data-driven pilots show 15–35% reductions; global regulatory alignment and advocacy partnerships will accelerate adoption.

Cross-Training & RBM: Case Studies Driving Faster Oncology Accrual

A community clinic's small changes — cross-trained staff, risk-based monitoring, and adaptive funnels — sped oncology enrollment and made trials more accessible to patients and caregivers.

Expert Guide: Federated Analytics & EHR Endpoints for Oncology Trials

How federated analytics and EHR endpoints are reshaping oncology trials: from privacy-preserving multi-site models to analytics-driven elderly recruitment in NYC and EHR-derived outcomes in HR+ breast cancer.

Optimize Fall Flu Enrollment: HR+ Therapy, Spironolactone & HNSCC

Use fall's momentum to boost enrollment: prioritize HR+ targeted adoption, repurpose spironolactone for seniors, leverage flu-season touchpoints, and seize HNSCC market opportunities with cost-aware, inclusive strategies.

Optimizing HR+ Breast Cancer Trials: Remote Monitoring, Consent & Cost

Data-driven trends show hybrid remote monitoring, low-literacy eConsent, and proactive financial mitigation will reshape HR+ breast cancer trials—boosting retention, safety and diversity.

How to Enroll Diverse Oncology Trials: Elderly, HR+ Breast & Head-Neck

Concrete, actionable steps to enroll elderly patients, HR+ breast cancer patients, and head & neck communities—using flexible visits, cultural brokers, language-accessible consent, and early clinical data manager input.